Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Published 12/05/2023, 18:09
Updated 12/05/2023, 19:10
© Reuters. Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga - Gainers

  • GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.
  • ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares jumped 82.8% to $8.27 after the company reported the FDA's Advisory Committee voted in support of favorable benefit-risk assessment for neffy in the treatment of severe allergic reactions (Type 1), including anaphylaxis.
  • Getaround, Inc. (NYSE: GETR) shares climbed 73.6% to $0.5749 after the company announced it is acquiring substantially all of the assets of HyreCar for an aggregate purchase price of $9.45 million.
  • Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares climbed 45.1% to $2.80 after the company highlighted recent corporate progress, and reported financial results for the first quarter.
  • Jupiter Wellness Acquisition Corp. (NASDAQ: JWAC) surged 40% to $7.10.
  • Blue Bird Corporation (NASDAQ: BLBD) gained 38.7% to $26.80 after the company reported better-than-expected Q2 results.
  • AirSculpt Technologies, Inc. (NASDAQ: AIRS) shares climbed 32.8% to $6.50 after the company reported better-than-expected Q1 financial results.
  • Arlo Technologies, Inc. (NASDAQ: ARLO) gained 24.3% to $8.76 following strong quarterly results.
  • Greenbrook TMS Inc. (NASDAQ: GBNH) rose 23.2% to $0.77.
  • First Solar, Inc. (NASDAQ: FSLR) surged 21.9% to $223.36 after the company announced the acquisition of Evolar.
  • Ouster, Inc. (NYSE: OUST) gained 19.3% to $4.58 following strong Q1 sales results.
  • VYNE Therapeutics Inc. (NASDAQ: VYNE) gained 19.3% to $7.28 after the company reported Q1 financial results.
  • Array Technologies, Inc. (NASDAQ: ARRY) jumped 18.6% to $22.47 following strong quarterly results.
  • SurgePays, Inc. (NASDAQ: SURG) gained 14.7% to $5.06 after the company reported Q1 financial results.
  • Pharming Group N.V. (NASDAQ: PHAR) rose 14.5% to $11.69. Pharming recently posted a Q1 loss of $0.02 per share.
  • P3 Health Partners Inc. (NASDAQ: PIII) jumped 14.3% to $2.64. P3 Health Partners recently posted upbeat quarterly results.
  • Holley Inc. (NYSE: HLLY) gained 12.8% to $3.07. Telsey Advisory Group and Raymond James raised their price targets on the stock.
  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) rose 9.3% to $1.29 following better-than-expected quarterly sales.
  • Hallmark Financial Services, Inc. (NASDAQ: HALL) gained 9.1% to $4.31.
  • News Corporation (NASDAQ: NWS) surged 6.7% to $17.97 following Q3 results.
Losers
  • Assure Holdings Corp. (NASDAQ: IONM) fell 37.8% to $1.20 after the company announced pricing of a $6 million underwritten public offering.
  • Heron Therapeutics, Inc. (NASDAQ: HRTX) dropped 33.9% to $1.4750 after the company reported mixed Q1 financial results.
  • TOP Financial Group Limited (NASDAQ: TOP) shares fell 29.7% to $6.42 after the SEC said it is temporarily suspending trading in the securities of the company because of "recent, unusual, and unexplained market activity" raising concerns regarding the adequacy and accuracy of publicly-available information.
  • AVITA Medical, Inc. (NASDAQ: RCEL) dropped 24.3% to $11.89 after the company reported mixed Q1 financial results.
  • Freight Technologies, Inc. (NASDAQ: FRGT) declined 23% to $1.54 after the company reported preliminary Q1 2023 revenue of $3.3 million, down from $5.3 million for Q1 prior year 2022.
  • Intrusion Inc. (NASDAQ: INTZ) dropped 22.9% to $1.31 following weak quarterly results.
  • BitNile Metaverse, Inc. (NASDAQ: BNMV) fell 22.3% to $0.0449 after the company announced a 1-for-30 reverse stock split.
  • Audacy, Inc. (NYSE: AUD) dropped 20.6% to $0.1086. Audacy recently reported mixed Q1 financial results.
  • Impel Pharmaceuticals Inc. (NASDAQ: IMPL) fell 19.7% to $1.83 after the company reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.
  • Check-Cap Ltd. (NASDAQ: CHEK) dropped 19% to $1.49 following a wider-than-expected quarterly loss.
  • Dingdong (Cayman) Limited (NYSE: DDL) fell 18.7% to $3.2820 after the company reported worse-than-expected Q1 sales results.
  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) fell 18.5% to $6.74.
  • Akumin Inc. (NASDAQ: AKU) dipped 18.4% to $0.4260. Akumin recently posted a wider quarterly loss.
  • ImmunityBio, Inc. (NASDAQ: IBRX) dropped 18% to $2.2850 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $10 to $4.
  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) dipped 17% to $6.86.
  • Cemtrex, Inc. (NASDAQ: CETX) fell 16.5% to $9.10 after the company reported Q2 results.
  • Harrow Health, Inc. (NASDAQ: HROW) dropped 16.3% to $22.66 after the company reported Q1 financial results.
  • VCI Global Limited (NASDAQ: VCIG) fell 14.8% to $3.00 after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
  • Youdao, Inc. (NYSE: DAO) dropped 14.4% to $5.42.
  • OraSure Technologies, Inc. (NASDAQ: OSUR) fell 13.8% to $6.37. OraSure Technologies recently posted upbeat quarterly results.
  • Emergent BioSolutions Inc. (NYSE: EBS) dropped 12.5% to $9.19. Emergent BioSolutions recently reported better-than-expected Q1 sales results.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) declined 10.6% to $8.27. Marinus Pharmaceuticals reported Q1 financial results.
  • IonQ, Inc. (NYSE: IONQ) shares fell 9.8% to $6.32 after the quantum computing company reported first-quarter financial results.
  • Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares dropped 9.7% to $0.7210. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
  • Definitive Healthcare Corp. (NASDAQ: DH) dropped 9% to $8.89.
  • MMTec, Inc. (NASDAQ: MTC) fell 8.2% to $1.01 after gaining more than 5% on Thursday.
  • Unique Fabricating, Inc. (NASDAQ: UFAB) fell 7.4% to $0.2453 after dropping 16% on Thursday.
  • IHS Holding Limited (NYSE: IHS) dropped 7.3% to $8.40.
  • BIOLASE, Inc. (NASDAQ: BIOL) shares dropped 6.8% to $0.2236 after the company posted Q1 results.

Now Read This: Bitcoin Tumbles Below This Key Level Following Economic Data; Pepe, Huobi Token Among Top Losers

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.